Zuellig likely to be passive investor in Ebos, MD Waller says

Zuellig likely to be passive investor in Ebos, MD Waller says
By Paul McBeth May 29 (BusinessDesk) - Privately-held Zuellig Group is likely to be a passive investor in Ebos Group as it takes a 40 percent stake in the local healthcare and veterinary products wholesaler as part of a $1.1 billion deal, Ebos managing director Mark Waller says. Hong Kong-based Zuellig will get $397 million in cash and take a $498 million cornerstone stake in Ebos as part of the sale of its Symbion pharmaceutical unit in Australia to the New Zealand company. Ebos will also take on net debt of $230 million, taking the total t...